Barnaby Page || 10th May 2016 || News analysis || Health and science | Regulation and Legislation | Geographies: North America United States
The U.S. Food and Drug Administration (FDA) believes most e-cigarette manufacturers will need to conduct fresh scientific research in order to obtain authorisation for their products under the newly-published deeming regulations – but not necessarily full-blown clinical studies.
Are you already a subscriber? login here Enjoy free subscription access Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors. Benefits of subscription plans: Stay informed of any legal and market change in the sector that impacts your organization Maximise resources by getting market and legal data analysis daily in one place Make smart decisions by understanding how the regulatory and market landscape evolves Anticipate risks in your decisions by monitoring regulatory changes that impact your organization